Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Aug 03, 2026
Marvell Technology (MRVL) Stock Drops -26.9% in 30 Days Amid Broad Semiconductor Selloff

Marvell Technology (MRVL) Stock Drops -26.9% in 30 Days Amid Broad Semiconductor Selloff

Key Takeaways

  • Marvell Technology shares dropped approximately 26.9% over the 30-day period ending August 3, 2026, falling from $245.29 to $179.32, driven primarily by a sector-wide semiconductor selloff rather than company-specific weakness.
  • The stock's dramatic decline erased gains from a parabolic rally that saw MRVL peak at $329.88 on June 18, with the drawdown fueled by AI capex sustainability fears, stretched valuations, and profit-taking after S&P 500 inclusion.
  • Quarterly performance tells a more complex story: despite the recent collapse, MRVL remains modestly positive over the trailing three months, reflecting the extreme volatility that has characterized the stock since its record-breaking spring surge.
  • Marvell's underlying business fundamentals remain strong, with record Q1 FY2027 revenue of $2.418 billion and Q2 guidance implying 35% year-over-year growth, supported by Nvidia's $2 billion strategic investment and an expanding custom AI silicon pipeline.
  • Wall Street maintains a "Moderate Buy" consensus with an average price target near $245, though valuation concerns, insider selling activity, and concentration risk among hyperscaler customers continue to weigh on sentiment.

Marvell Technology (MRVL) Company Overview and Market Position

Marvell Technology, Inc. is a global semiconductor company that designs and develops integrated circuits and related software for data infrastructure, networking, storage, and connectivity markets. The company's product portfolio spans system-on-chip (SoC) solutions, Ethernet physical-layer transceivers, switch silicon, optical interconnect components, storage controllers, and security processors. Marvell's technology powers high-performance data centers, carrier networks, enterprise and cloud storage, as well as connectivity in automotive and industrial applications. With data center revenue now representing 76% of total sales, Marvell has positioned itself as a critical supplier of custom AI silicon and networking products — a role that has drawn heightened investor attention and a $2 billion strategic investment from Nvidia. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Marvell Technology (MRVL) Stock Price Performance: Last 30 Days vs. Quarter

Over the 30-day period ending August 3, 2026, MRVL shares declined approximately 26.9%, falling from a closing price of $245.29 on July 2 to $179.32. The selloff was not linear; the stock experienced multiple sharp down days, including an 8.4% single-session plunge following TSMC's capex guidance raise, and a 6.5% drop on July 15 triggered in part by an Erste Group downgrade to Hold. By late July, MRVL touched an intraday low of $162.90 before staging a modest recovery.

The quarterly picture is markedly different. From early May 2026, when shares traded near $165, the stock embarked on an extraordinary rally that propelled it to an all-time high of $329.88 on June 18 — a near-doubling in roughly six weeks. The catalyst-rich period included record Q1 FY2027 earnings, S&P 500 index inclusion on June 22, and a series of bullish analyst notes. However, the quarter ended with a violent reversal: after peaking, the stock surrendered more than half its value in just over a month, leaving it only modestly above its early-May starting point despite the intervening euphoria. This extreme round-trip underscores the heightened volatility that now defines MRVL's trading profile, with a beta of approximately 2.2 amplifying moves in both directions. From what I see, this level of volatility warrants close monitoring with tools like Tickeron’s AI Trend Prediction Engine.

What Drove MRVL Stock Price in the Last 30 Days

The 30-day decline in Marvell shares was overwhelmingly driven by macro and sector-level forces rather than company-specific deterioration. The primary trigger was a broad semiconductor selloff that began when TSMC raised its 2026 capital expenditure guidance to $60–$64 billion while simultaneously warning that overseas expansion and 2-nanometer ramp costs would pressure gross margins. The market interpreted this as a signal that scaling AI manufacturing capacity would be exceptionally expensive, triggering a multiple de-rating across the chip complex. Marvell, trading at a trailing P/E above 65x at the time, absorbed disproportionate selling.

Compounding the pressure, Erste Group downgraded MRVL to Hold on July 15, explicitly citing valuation concerns despite acknowledging the company's strong guidance. The downgrade reinforced growing unease about whether the stock's premium pricing could be justified even with projected earnings growth of 42% in FY2027 and 66% in FY2028. Concurrently, reports that former CFO Willem Meintjes filed to sell approximately 207,000 shares — roughly 48% of his holdings — near the stock's highs added a cautionary signal for investors already nervous about the pace of the prior advance.

Broader macro headwinds also played a significant role. Renewed speculation around Federal Reserve rate increases, geopolitical tensions in the Middle East, and a rotation out of high-beta growth names into defensive sectors all contributed to a risk-off environment. The iShares Semiconductor ETF (SOXX) declined sharply, and Marvell — one of the year's best-performing semiconductor stocks — became a natural source of funds for traders seeking to reduce exposure. Crucially, none of these developments reflected deterioration in Marvell's underlying business, which continued to benefit from record AI-related bookings and a raised revenue outlook for fiscal years 2027 and 2028.

What Drove MRVL Stock Performance Over the Last Quarter

The quarterly narrative is defined by two distinct phases: an explosive rally followed by a punishing correction. The rally phase was driven by genuine fundamental strength. On May 27, Marvell reported Q1 FY2027 revenue of $2.418 billion — up 27.6% year-over-year — and guided Q2 to $2.7 billion at the midpoint, implying roughly 35% growth. CEO Matt Murphy cited "exceptional AI-related bookings" and significantly raised the company's fiscal 2027 and 2028 outlooks. The company also closed acquisitions of Celestial AI and XConn Technologies in February 2026, strengthening its photonic interconnect and chiplet connectivity capabilities.

The rally accelerated dramatically in early June, fueled by Nvidia CEO Jensen Huang's appearance at Computex 2026, where he described Marvell as a potential "trillion-dollar company." The endorsement, combined with Nvidia's $2 billion strategic investment and the integration of Marvell's custom silicon into the NVLink Fusion ecosystem, sent shares soaring. S&P 500 inclusion on June 22 provided additional passive-index buying, pushing the stock to its $329.88 peak.

The correction phase that followed was equally extraordinary. As the initial wave of index-driven buying subsided, profit-taking ensued. By July, fears about AI infrastructure spending sustainability — triggered by TSMC's capex reset and concerns about hyperscaler budget discipline — sparked a systematic de-risking across the semiconductor sector. Marvell's high beta and previously stretched valuation meant it bore the brunt of the selling, with the stock ultimately retreating to levels last seen before the June rally. The quarter thus ended as a dramatic round-trip that left the stock modestly higher but underscored its vulnerability to shifts in AI sentiment.

MRVL Stock Forecast Drivers: What Investors Should Watch Next

Marvell's next quarterly earnings report, expected in late August 2026, represents the most immediate catalyst. Consensus estimates call for EPS of approximately $0.87–$0.93 on revenue of roughly $2.7 billion. Investors will scrutinize whether AI-related demand continues accelerating at the pace management projected, particularly in custom ASIC programs tied to Amazon's Trainium 3 ramp and potential new design wins with Alphabet. Any downward revision to the fiscal 2027 or 2028 revenue outlook could reignite valuation concerns, while an upward surprise could help stabilize the stock after its dramatic correction.

Beyond earnings, the trajectory of hyperscaler capital expenditure remains the dominant macro theme. With aggregate 2026 cloud provider spending plans approaching $700 billion, any sign of belt-tightening would disproportionately affect Marvell given its 76% data center revenue concentration. The competitive landscape also warrants monitoring: Broadcom remains a formidable rival in both custom silicon and networking, and the evolving dynamics between NVLink and the UALink open standard could shape Marvell's addressable market. Finally, Federal Reserve policy direction, semiconductor sector fund flows, and insider transaction patterns will continue to influence short-term price action in this high-beta name.

Trending AI Robots

When navigating volatile names like MRVL, I often turn to Tickeron’s Trending AI Robots. This curated selection highlights top-performing AI trading bots with transparent performance metrics and strategy details, helping align approaches with specific trading objectives in today’s markets.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MRVL

MRVL in downward trend: price dove below 50-day moving average on July 13, 2026

MRVL moved below its 50-day moving average on July 13, 2026 date and that indicates a change from an upward trend to a downward trend. In of 39 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MRVL as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for MRVL crossed bearishly below the 50-day moving average on July 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRVL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MRVL entered a downward trend on July 31, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MRVL's RSI Oscillator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where MRVL advanced for three days, in of 319 cases, the price rose further within the following month. The odds of a continued upward trend are .

MRVL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MRVL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.242) is normal, around the industry mean (15.194). P/E Ratio (64.454) is within average values for comparable stocks, (218.742). Projected Growth (PEG Ratio) (1.060) is also within normal values, averaging (1.896). MRVL has a moderately low Dividend Yield (0.001) as compared to the industry average of (0.016). P/S Ratio (18.797) is also within normal values, averaging (41.978).

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Analog Devices (NASDAQ:ADI), Marvell Technology (NASDAQ:MRVL), QUALCOMM (NASDAQ:QCOM).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 176.81B. The market cap for tickers in the group ranges from 13.43K to 4.86T. NVDA holds the highest valuation in this group at 4.86T. The lowest valued company is CYBL at 13.43K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was -0%. For the same Industry, the average monthly price growth was -11%, and the average quarterly price growth was 42%. PI experienced the highest price growth at 19%, while NXPI experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was -7%. For the same stocks of the Industry, the average monthly volume growth was -14% and the average quarterly volume growth was -45%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 60
P/E Growth Rating: 51
Price Growth Rating: 52
SMR Rating: 75
Profit Risk Rating: 74
Seasonality Score: -22 (-100 ... +100)
View a ticker or compare two or three
MRVL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company which engages in the business of providing semiconductors to high-performance application-specific standard products

Industry Semiconductors

Profile
Details
Industry
Semiconductors
Address
1000 N. West Street
Phone
+1 302 295-4840
Employees
7480
Web
https://www.marvell.com
Interact to see
Advertisement
Chevron’s upcoming Q4 report highlights its first full quarters integrating Hess, following record Q3 production of 4.1 million barrels of oil equivalent per day (MMboe/d). Comparing CVX with ExxonMobil and Shell provides insight into how each supermajor is navigating a volatile oil market with prices hovering below $60 per barrel.
SoFi Technologies is set to report Q4 and full-year 2025 earnings on January 30, 2026, closing out a pivotal year for the digital finance platform. With its fiscal year ending December 31, the report follows a strong Q3 that featured record net revenue of $962 million and member growth to 12.6 million, a 35% year-over-year increase.
ASML reported Q4 2025 net sales of $9.7 billion, gross margin of 52.2%, net income of $2.8 billion, and record net bookings of $13.2 billion, including $7.4 billion in EUV orders.
IDEXX Laboratories (IDXX) reports Q4 2025 earnings on February 2, 2026, with analysts expecting continued strength in recurring revenue from companion animal diagnostics. Danaher (DHR) reports on January 28, while Thermo Fisher Scientific (TMO) follows in early February, with both facing low-single-digit core growth expectations across life sciences and diagnostics.
NIO Inc. (NIO) produced its one-millionth vehicle this week at its Hefei facility, closing out a record 2025 delivery total of 326,028 units, up 46.9% year over year. The milestone, announced January 6, reflects accelerating demand for core models such as the ES8 SUV and newer brands ONVO and Firefly.
Faraday Future Intelligent Electric Inc. (FFAI) shares traded near $1.02 this week following announcements of a non-binding $10 million stock purchase term sheet with AIxCrypto (AIxC) and preparations for a Stockholders’ Day on January 7, 2026. Trading volume spiked amid broader EV volatility, highlighting investor attention on FFAI’s pivot toward AI-enhanced mobility and robotics.
BTQ Technologies Corp. (BTQ), formerly BTQQF, launched the Bitcoin Quantum testnet this week—the first quantum-safe Bitcoin fork, 17 years after Bitcoin’s genesis block. The move coincided with inclusion in the $524.5 million VanEck Quantum Computing UCITS ETF, boosting European investor visibility.
VEU targets large- and mid-cap ex-U.S. stocks with ~3,800 holdings. VXUS offers broad all-cap exposure, including ~8,600 stocks across small-, mid-, and large-cap companies.
Apple (AAPL) reports Q1 FY2026 earnings on January 29, with consensus revenue at $138.5B and EPS at $2.67, supported by strong demand for iPhone 17 models, higher average selling prices, and continued Services growth. Microsoft (MSFT) reports Q2 FY2026 on January 28, expecting $80.3B revenue and $3.91 EPS, driven by Azure AI adoption and enterprise cloud expansion, though elevated capex spending (~$35B/quarter) remains under scrutiny.
Visa Inc. (V), the global payments network leader, reports Q1 FY2026 earnings on January 29, 2026, for the period ending December 31, 2025. This marks the start of FY2026 following a strong FY2025, where net revenue reached $40 billion (+11%) and EPS climbed to $11.47 (+14%). Investors are watching closely for insights into consumer spending, cross-border travel recovery, and digital payment adoption.
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.